Uridine diphosphate glucuronosyltransferase (UG... [J Clin Oncol. 2006] - PubMed

Review Pharmacogenomics of tamoxifen and irinotecan therapies. [Clin Lab Med. 2008]
Review Pharmacogenomics of tamoxifen and irinotecan therapies.
Algeciras-Schimnich A, O'Kane DJ, Snozek CL. Clin Lab Med. 2008 Dec; 28(4):553-67.
Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping. [Pharmacogenomics. 2006]
Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping.
Innocenti F, Ratain MJ. Pharmacogenomics. 2006 Dec; 7(8):1211-21.
Review Pharmacogenetic approach for cancer treatment-tailored medicine in practice. [Ann N Y Acad Sci. 2006]
Review Pharmacogenetic approach for cancer treatment-tailored medicine in practice.
Hasegawa Y, Ando Y, Ando M, Hashimoto N, Imaizumi K, Shimokata K. Ann N Y Acad Sci. 2006 Nov; 1086:223-32.
UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer. [Br J Cancer. 2004]
UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer.
Marcuello E, Altés A, Menoyo A, Del Rio E, Gómez-Pardo M, Baiget M. Br J Cancer. 2004 Aug 16; 91(4):678-82.
Severe irinotecan-induced toxicities in a patient with uridine diphosphate glucuronosyltransferase 1A1 polymorphism. [Clin Colorectal Cancer. 2005]
Severe irinotecan-induced toxicities in a patient with uridine diphosphate glucuronosyltransferase 1A1 polymorphism.
Mehra R, Murren J, Chung G, Smith B, Psyrri A. Clin Colorectal Cancer. 2005 May; 5(1):61-4.

A humanized UGT1 mouse model expressing the UGT1A1*28 allele for assessing drug clearance by UGT1A1-dependent glucuronidation. [Drug Metab Dispos. 2010]
A humanized UGT1 mouse model expressing the UGT1A1*28 allele for assessing drug clearance by UGT1A1-dependent glucuronidation.
Cai H, Nguyen N, Peterkin V, Yang YS, Hotz K, La Placa DB, Chen S, Tukey RH, Stevens JC. Drug Metab Dispos. 2010 May; 38(5):879-86. Epub 2010 Feb 2.
Review Pharmacogenetics of solid tumors: directed therapy in breast, lung, and colorectal cancer: a paper from the 2008 william beaumont hospital symposium on molecular pathology. [J Mol Diagn. 2009]
Review Pharmacogenetics of solid tumors: directed therapy in breast, lung, and colorectal cancer: a paper from the 2008 william beaumont hospital symposium on molecular pathology.
Snozek CL, O'Kane DJ, Algeciras-Schimnich A. J Mol Diagn. 2009 Sep; 11(5):381-9. Epub 2009 Jul 30.
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors. [Cancer Chemother Pharmacol. 2009]
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors.
Denlinger CS, Blanchard R, Xu L, Bernaards C, Litwin S, Spittle C, Berg DJ, McLaughlin S, Redlinger M, Dorr A, et al. Cancer Chemother Pharmacol. 2009 Dec; 65(1):97-105. Epub 2009 May 5.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Uridine diphosphate glucuronosyltransferase (UGT) 1A1 and irinotecan: practical ...
Uridine diphosphate glucuronosyltransferase (UGT) 1A1 and irinotecan: practical pharmacogenomics arrives in cancer therapy.
J Clin Oncol. 2006 Oct 1 ;24(28):4534-8.

PubMed
Does open access in ophthalmology affect how articles are subsequently cited in ...
Does open access in ophthalmology affect how articles are subsequently cited in research?
Ophthalmology. 2009 Aug ;116(8):1425-31. Epub 2009 Jul 9 .

PubMed
Biochemical basis of enhanced drug bioavailability by piperine: evidence that pi...
Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.
J Pharmacol Exp Ther. 1985 Jan ;232(1):258-62.

PubMed
Physical exercise and cognitive recovery in acquired brain injury: a review of t...
Physical exercise and cognitive recovery in acquired brain injury: a review of the literature.
PM R. 2009 Jun ;1(6):560-75.

PubMed
Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurn...
Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity.
Clin Exp Allergy. 2003 Mar ;33(3):337-41.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed